Publication details
Panitumumab
| Authors | |
|---|---|
| Year of publication | 2008 |
| Type | Article in Periodical |
| Magazine / Source | Remedia |
| MU Faculty or unit | |
| Citation | |
| Field | Oncology and hematology |
| Keywords | panitumumab ABX-EGF monoclonal antibody targeted therapy EGFR colorectal cancer head and neck cancer |
| Description | Panitumumab is fully humanized monoclonal antibody directed against the epidermal growth factor receptor, expressed in variety of tumors. It is a targeted therapy. Attention is being paid to the identification of oncological indications and predictive markers of this therapy. |